Helocyte, Inc. — Form D

Helocyte, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2016-07-15. The offering totals $5.0M, of which $1.0M was reported sold. Industry: Biotechnology.

Offering

Filed: 2016-07-15
Form: D
Accession: 0001679808-16-000001
Industry: Biotechnology
Exemptions: 06b
Total offering: $5.0M
Amount sold: $1.0M
Remaining: $4.0M
Investors: 11
Date of first sale: 2016-06-30
Security types: debt
Revenue range: Decline to Disclose
SEC file number: 021-267116

Issuer

Name: Helocyte, Inc.
CIK: 0001679808
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2015
Address: 2 GANSEVOORT STREET, NEW YORK, NY, 10014
Phone: 212-554-4520

Officers, directors & promoters (7)

Name	Role	Location
Frank Taffy	Director	Hoboken, NJ
Frank Taffy	Executive Officer	Hoboken, NJ
Kenneth W Cappell	Director	New Yor, NY
Elizabeth Clark Moore	Executive Officer	New York, NY
DAVID J HORIN	Executive Officer	NEW YORK, NY
Michael S Weiss	Director	New York, NY
Lindsay A Rosenwald	Director	New York, NY

Other filings by this issuer (2)

Filed	Form	Offering	Sold
2016-11-04	D/A	$5.0M	$4.0M
2016-10-14	D/A	$5.0M	$3.0M

More